Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 1921 AL 1935

Therapeutic nanotechnologies for Alzheimer's disease: A critical analysis of recent trends and findings

Delbreil P, Rabanel JM, Banquy X, Brambilla D.

Adv Drug Deliv Rev. 2022 Aug;187:114397. doi: 10.1016/j.addr.2022.114397. Epub 2022 Jun 20.

Current Progress on Neuroprotection Induced by Artemisia, Ginseng, Astragalus, and Ginkgo Traditional Chinese Medicines for the Therapy of Alzheimer's Disease

Li Q, Rubin L, Silva M, Li S, Yang C, Lazarovici P, Zheng W.

Oxid Med Cell Longev. 2022 Jun 14;2022:3777021. doi: 10.1155/2022/3777021. eCollection 2022.

Targeting gut microbiota to alleviate neuroinflammation in Alzheimer's disease

Thu Thuy Nguyen V, Endres K.

Adv Drug Deliv Rev. 2022 Sep;188:114418. doi: 10.1016/j.addr.2022.114418. Epub 2022 Jul 3.

Efficacy and safety of sodium oligomannate in the treatment of Alzheimer's disease

Zhang LF, Zhang YP, Lin PX, Xue LH.

Pak J Pharm Sci. 2022 May;35(3):741-745.

How a Medicare payment model is affecting care for older adults with Alzheimer's disease and related dementias

Hung A, Hall R.

J Am Geriatr Soc. 2022 Sep;70(9):2478-2480. doi: 10.1111/jgs.17948. Epub 2022 Jul 6.

Therapeutic Potential of Allicin and Aged Garlic Extract in Alzheimer's Disease

Tedeschi P, Nigro M, Travagli A, Catani M, Cavazzini A, Merighi S, Gessi S.

Int J Mol Sci. 2022 Jun 22;23(13):6950. doi: 10.3390/ijms23136950.

Role of Natural Compounds and Target Enzymes in the Treatment of Alzheimer's Disease

Wang S, Kong X, Chen Z, Wang G, Zhang J, Wang J.

Molecules. 2022 Jun 29;27(13):4175. doi: 10.3390/molecules27134175.

The design and conduct of a pragmatic cluster randomized trial of an advance care planning program for nursing home residents with dementia

Hickman SE, Mitchell SL, Hanson LC, Tu W, Stump TE, Unroe KT.

Clin Trials. 2022 Dec;19(6):623-635. doi: 10.1177/17407745221108992. Epub 2022 Jul 10.

Editorial: The dawn of a new era of Alzheimer's research and drug development

Hara Y, Fillit HM.

J Prev Alzheimers Dis. 2022;9(3):385-386. doi: 10.14283/jpad.2022.64.

Tackling a Major Deficiency of Diversity in Alzheimer's Disease Therapeutic Trials: An CTAD Task Force Report

Raman R, Aisen PS, Carillo MC, Detke M, Grill JD, Okonkwo OC, Rivera-Mindt M, Sabbagh M, Vellas B, Weiner M, Sperling R.

J Prev Alzheimers Dis. 2022;9(3):388-392. doi: 10.14283/jpad.2022.50.

Effects of Non-Invasive Brain Stimulation on Alzheimer's Disease

Gu L, Xu H, Qian F.

J Prev Alzheimers Dis. 2022;9(3):410-424. doi: 10.14283/jpad.2022.40.

Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe Alzheimer's Disease: A Double-Blind Masked Clinical Trial for Dose Finding

Ruiz A, Sánchez D, Lafuente A, Ortega G, Buendía M, Papasey J, Jimeno SY, Badia FP, Palacio ME, Abdelnour C, Ramírez-Toraño F, Maestú F, Sáez ME, Tárraga L, Dagnelie PC, Boada M.

J Prev Alzheimers Dis. 2022;9(3):425-434. doi: 10.14283/jpad.2022.38.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias